Showing results (21-30 of 80) with videos related to
Sort By:
Pageof 8
Antiviral Therapy|November 3, 2010
Occult HBV infection in untreated HIV-infected adults in Côte d'IvoireThérèse N'Dri-Yoman, Xavier Anglaret, Eugène Messou, et al.Antiviral Therapy|June 3, 2010
CD4+ T-cell-guided structured treatment interruptions of antiretroviral therapy in HIV disease: projecting beyond clinical trialsYazdan Yazdanpanah, Lindsey L Wolf, Xavier Anglaret, et al.AIDS Research and Human Retroviruses|July 22, 2009
Medium-term probability of success of antiretroviral treatment after early warning signs of treatment failure in West African adultsChristine Danel, Delphine Gabillard, Andre Inwoley, et al.HIV Medicine|January 13, 2022
Plasma sVCAM-1, antiretroviral therapy and mortality in HIV-1-infected West African adultsRoseline Affi, Delphine Gabillard, Gérard Menan Kouame, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|December 31, 2010
Association between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Côte d'IvoireEugène Messou, Marie-Laure Chaix, Delphine Gabillard, et al.AIDS Research and Human Retroviruses|February 1, 2007
Lack of indinavir-associated nephrological complications in HIV-infected adults (predominantly women) with high indinavir plasma concentration in Abidjan, Côte d'IvoireChristine Danel, Raoul Moh, Gilles Peytavin, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|October 27, 2011
CD4-specific mortality rates among HIV-infected adults with high CD4 counts and no antiretroviral treatment in West AfricaCharlotte Lewden, Delphine Gabillard, Albert Minga, et al.The Journal of Infectious Diseases|November 7, 2008
Two-months-off, four-months-on antiretroviral regimen increases the risk of resistance, compared with continuous therapy: a randomized trial involving West African adultsChristine Danel, Raoul Moh, Marie-Laure Chaix, et al.Journal of Gastroenterology and Hepatology|August 28, 2015
Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan AfricaAnders Boyd, Sarah Maylin, Raoul Moh, et al.Liver International : Official Journal of the International Association for the Study of the Liver|September 27, 2018
Effect of hepatitis B virus (HBV) surface-gene variability on markers of replication during treated human immunodeficiency virus-HBV infection in Western AfricaAnders Boyd, Raoul Moh, Sarah Maylin, et al.Pageof 8